The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ELCC 2018 | The role of the pathologist in the field of lung cancer

Name: The role of the pathologist in the field of lung cancer
Uploaded: 2018-04-11T00:00:00.000Z
Duration: 1 min 44 s
Description: Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Keith Kerr, MB, ChB, FRCPath, FRCPE, from the University of Aberdeen, Aberdeen, UK, describes the increasing complexity of the role of pathologists in the field of lung cancer, with an increasing number of assays required for appropriate treatment selection.

Keith Kerr • 11 Apr 2018

ELCC 2018

Lung Cancer Non-Small Cell Lung Cancer Small Cell Lung Cancer

Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Keith Kerr, MB, ChB, FRCPath, FRCPE, from the University of Aberdeen, Aberdeen, UK, describes the increasing complexity of the role of pathologists in the field of lung cancer, with an increasing number of assays required for appropriate treatment selection.